Signaling Molecules as Promising Drug Targets for the Treatment of Psoriasis

Author Information
Article Notes and Dates
To Cite : Jadali Z. Signaling Molecules as Promising Drug Targets for the Treatment of Psoriasis, J Skin Stem Cell. 2015 ;2(3):e31934. doi: 10.17795/jssc31934.
Copyright: Copyright © 2015, Journal of Skin and Stem Cell. .
References
  • 1. Jadali Z, Eslami MB. T cell immune responses in psoriasis. Iran J Allergy Asthma Immunol. 2014; 13(4): 220-30[PubMed]
  • 2. Sehgal VN, Pandhi D, Khurana A. Biologics in dermatology: an integrated review. Indian J Dermatol. 2014; 59(5): 425-41[DOI][PubMed]
  • 3. Rongioletti F, Burlando M, Parodi A. Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data. G Ital Dermatol Venereol. 2014; 149(3): 311-6[PubMed]
  • 4. Hsu L, Armstrong AW. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. J Immunol Res. 2014; 2014: 283617[DOI][PubMed]
  • 5. Belge K, Brück J, Ghoreschi K. Advances in treating psoriasis. F1000prime reports. 2014; 6
  • 6. Mocsai A, Kovacs L, Gergely P. What is the future of targeted therapy in rheumatology: biologics or small molecules? BMC Med. 2014; 12: 43[DOI][PubMed]
  • 7. Gadina M. Janus kinases: an ideal target for the treatment of autoimmune diseases. J Investig Dermatol Symp Proc. 2013; 16(1)-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Journal of Skin and Stem Cell accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check